{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:42Z","timestamp":1792783722878,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"vor","delay-in-days":366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NCI-R01CA121249A501"],"award-info":[{"award-number":["NCI-R01CA121249A501"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P20 RR-017698"],"award-info":[{"award-number":["P20 RR-017698"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"USC Behavioral-Biomedical Interface Program"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bbadis.2014.12.015","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T12:41:35Z","timestamp":1419943295000},"page":"816-825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Sex differences in the relationship of IL-6 signaling to cancer cachexia progression"],"prefix":"10.1016","volume":"1852","author":[{"given":"Kimbell L.","family":"Hetzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin P.","family":"Hardee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa J.","family":"Puppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi A.","family":"Narsale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2014.12.015_bb0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13539-013-0105-y","article-title":"Cachexia as a major public health problem: frequent, costly, and deadly","volume":"4","author":"Farkas","year":"2013","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0010","first-page":"251","article-title":"Crossroads of cytokine signaling \u2014 the chase to stop muscle cachexia","volume":"59","author":"Pajak","year":"2008","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia\u2014pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/japplphysiol.00442.2010","article-title":"Activity level, apoptosis, and development of cachexia in Apc min\/+ mice","volume":"109","author":"Baltgalvis","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0025","doi-asserted-by":"crossref","first-page":"e24650","DOI":"10.1371\/journal.pone.0024650","article-title":"The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min\/+) mouse","volume":"6","author":"White","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0030","doi-asserted-by":"crossref","first-page":"R201","DOI":"10.1152\/ajpregu.00300.2010","article-title":"Muscle oxidative capacity during IL-6 dependent cancer cachexia","volume":"300","author":"White","year":"2011","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","article-title":"The effect of exercise on IL-6 induced cachexia in the Apc min\/+ mouse","volume":"3","author":"Puppa","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0045","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","article-title":"Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner","volume":"71","author":"Cosper","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13539-012-0060-z","article-title":"Effect of sexual dimorphism on muscle strength in cachexia","volume":"3","author":"Norman","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2008.11.002","article-title":"Chemokines and the microenvironment in neuroectodermal tumor\u2013host interaction","volume":"19","author":"Somasundaram","year":"2009","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0060","doi-asserted-by":"crossref","first-page":"e67654","DOI":"10.1371\/journal.pone.0067654","article-title":"Metabolomic profiles are gender, disease, and time specific in the interleukin-10 gene-deficient mouse model of inflammatory bowel disease","volume":"8","author":"Tso","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/ATVBAHA.108.182279","article-title":"Estrogen and mechanisms of vascular protection","volume":"29","author":"Xing","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yjmcc.2005.06.019","article-title":"17-beta-estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia","volume":"40","author":"Wang","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0075","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/endo.142.7.8243","article-title":"Differential effects of estradiol on the adrenocorticotropin responses to interleukin-6 and interleukin-1 in the monkey","volume":"142","author":"Xiao","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0080","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1111\/j.1582-4934.2009.00669.x","article-title":"Akt mediates 17beta-estradiol and\/or estrogen receptor-alpha inhibition of LPS-induced tumor necrosis factor-alpha expression and myocardial cell apoptosis by suppressing the JNK1\/2-NFkB pathway","volume":"13","author":"Liu","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11010-012-1482-9","article-title":"Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein","volume":"373","author":"Cossette","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0090","doi-asserted-by":"crossref","first-page":"31839","DOI":"10.1074\/jbc.M105185200","article-title":"Activation of estrogen receptor blocks interleukin-6-inducible cell growth of human multiple myeloma involving molecular cross-talk between estrogen receptor and STAT3 mediated by co-regulator PIAS3","volume":"276","author":"Wang","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0095","doi-asserted-by":"crossref","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in Apc min\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Scheede-Bergdahl","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3346\/jkms.2012.27.2.128","article-title":"Pathophysiological role of hormones and cytokines in cancer cachexia","volume":"27","author":"Kim","year":"2012","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0110","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db09-1316","article-title":"Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome","volume":"59","author":"Nikolajuk","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0115","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.4049\/jimmunol.1003587","article-title":"IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes","volume":"186","author":"Lee","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1155\/2014\/168407","article-title":"Inflammation based regulation of cancer cachexia","volume":"2014","author":"Onesti","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0125","doi-asserted-by":"crossref","first-page":"C140","DOI":"10.1152\/ajpcell.00047.2009","article-title":"Downregulation of cilia-localized IL-6R alpha by 17beta-estradiol in mouse and human fallopian tubes","volume":"297","author":"Shao","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0130","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/CS20110340","article-title":"IL-6\/IL-6 receptor system and its role in physiological and pathological conditions","volume":"122","author":"Mihara","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.bcp.2012.11.021","article-title":"Interleukin-6 induces vascular endothelial growth factor expression and promotes angiogenesis through apoptosis signal-regulating kinase 1 in human osteosarcoma","volume":"85","author":"Tzeng","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022538","article-title":"STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia","volume":"6","author":"Bonetto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0150","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","article-title":"Muscle wasting and interleukin-6-induced atrogin1 expression in the cachectic Apc min\/+ mouse","volume":"457","author":"Baltgalvis","year":"2009","journal-title":"Pfl\u00fcgers Arch."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0155","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1152\/japplphysiol.00778.2005","article-title":"Myofiber degeneration\/regeneration is induced in the cachectic Apc min\/+ mouse","volume":"99","author":"Mehl","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0160","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc min\/+ mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0165","doi-asserted-by":"crossref","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc min\/+ mouse","volume":"2","author":"White","year":"2012","journal-title":"Skelet. Muscle"},{"issue":"12","key":"10.1016\/j.bbadis.2014.12.015_bb0170","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1242\/bio.20136544","article-title":"Characterization of the male Apc min\/+ mouse as a hypogonadism model related to cancer cachexia","volume":"2","author":"White","year":"2013","journal-title":"Biol. Open."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0175","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.atherosclerosis.2006.10.022","article-title":"Sex differences in the association between leptin and CRP: results from the Dallas Heart Study","volume":"195","author":"Abdullah","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0897.2011.01052.x","article-title":"Immunological differences in women compared with men: overview and contributing factors","volume":"66","author":"Ghazeeri","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0185","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1126\/science.1140485","article-title":"Gender disparity in liver cancer due to sex differences in MYD88-dependent IL-6 production","volume":"317","author":"Naugler","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0190","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1172\/JCI117100","article-title":"17 beta estradiol inhibits expression of human interleukin 6 promoter reporter constructs by a receptor-dependent mechanism","volume":"93","author":"Pottratz","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0195","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.maturitas.2008.09.024","article-title":"Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6","volume":"61","author":"Edwards","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0200","doi-asserted-by":"crossref","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bbadis.2014.12.015_bb0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13539-011-0047-1","article-title":"The effect of exercise on IL-6-induced cachexia in the Apc (Min\/+) mouse","volume":"3","author":"Puppa","year":"2012","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.bbadis.2014.12.015_bb0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apha.12168","article-title":"The homeobox gene Six1 alters myosin heavy chain isoform expression in mouse skeletal muscle","volume":"210","author":"Hetzler","year":"2013","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0215","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0220","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2478\/raon-2014-0025","article-title":"The effect of radiation dose on mouse skeletal muscle remodeling","volume":"48","author":"Hardee","year":"2014","journal-title":"Radiol. Oncol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0225","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cyto.2013.12.011","article-title":"Effects of the MCP-1 synthesis inhibitor bindarit on tumorigenesis and inflammatory markers in the C3(1)\/SV40Tag mouse model of breast cancer","volume":"66","author":"Steiner","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0230","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1152\/japplphysiol.00975.2004","article-title":"Decreased intestinal polyp multiplicity is related to exercise mode and gender in Apc min\/+ mice","volume":"98","author":"Mehl","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0235","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/01635581.2011.535954","article-title":"Quercetin's effects on intestinal polyp multiplicity and macrophage number in the Apc min\/+ mouse","volume":"63","author":"Murphy","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0240","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2613.2006.00477.x","article-title":"Developmental abnormalities in multiple proliferative tissues of Apc min\/+ mice","volume":"87","author":"You","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0245","first-page":"312","article-title":"Steep elevation of blood interleukin-6 (IL-6) associated only with late stage of cachexia in cancer patients","volume":"15","author":"Iwase","year":"2004","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N","article-title":"The role of cytokines in cancer cachexia","volume":"19","author":"Argiles","year":"1999","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0255","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1007\/s00520-013-1878-4","article-title":"Interleukin-6 but not tumor necrosis factor-alpha predicts survival in patients with advanced cancer","volume":"21","author":"Suh","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0260","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1016\/j.jpainsymman.2013.01.009","article-title":"Favorable responses to Tocilizumab in two patients with cancer-related cachexia","volume":"46","author":"Gandolfi","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0265","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","article-title":"Possible role for Tocilizumab, and anti-interleukin-6 receptor antibody, in treating cancer cachexia","volume":"31","author":"Ando","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bbadis.2014.12.015_bb0270","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1507\/endocrj.EJ13-0455","article-title":"Distinct metabolic effects following short-term exposure of different high-fat diets in male and female mice","volume":"61","author":"Senthil Kumar","year":"2014","journal-title":"Endocr. J."},{"issue":"1","key":"10.1016\/j.bbadis.2014.12.015_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yhbeh.2014.02.007","article-title":"Sexual dimorphism in white and brown adipose tissue with obesity and inflammation","volume":"66","author":"Bloor","year":"2014","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0285","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-357","article-title":"Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy","volume":"14","author":"Ruzzo","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","article-title":"Interleukin-6 as a key regulator of muscle mass during cachexia","volume":"38","author":"Carson","year":"2010","journal-title":"Exerc. Sport Sci. Rev."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jnci\/94.8.617","article-title":"Reproductive hormone-induced STAT3-mediated interleukin-6 action in normal and malignant human ovarian surface epithelial cells","volume":"94","author":"Syed","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0300","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/0008-5472.CAN-10-1496","article-title":"IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer","volume":"71","author":"Lo","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0305","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cyto.2012.10.023","article-title":"Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients","volume":"61","author":"Batista","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0310","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI23640","article-title":"The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury","volume":"115","author":"Klein","year":"2005","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0315","first-page":"287","article-title":"Interleukin 6\/Interleukin 6 receptor interaction and its role as a therapeutic target for treatment of cachexia and cancer","volume":"7","author":"Weidle","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.bbadis.2014.12.015_bb0320","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11596-014-1281-5","article-title":"SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF","volume":"34","author":"Li","year":"2014","journal-title":"J. Huazhong Univ. Sci. Technol."},{"issue":"9","key":"10.1016\/j.bbadis.2014.12.015_bb0325","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/art.38701","article-title":"Suppressor of cytokine signaling-3 regulates gp130 cytokine-induced signaling to limit chondrocyte responses during inflammatory arthritis","volume":"66","author":"Liu","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0330","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10735-011-9317-7","article-title":"Suppressor of cytokine signaling protein SOCS3 expression is increased at sites of acute and chronic inflammation","volume":"42","author":"White","year":"2011","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.bbadis.2014.12.015_bb0335","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1073\/pnas.1315862110","article-title":"STAT3 activation in response to IL-6 is prolonged by the binding of the IL-6 receptor to EGF receptor","volume":"110","author":"Wang","year":"2013","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914004098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443914004098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T22:58:04Z","timestamp":1566169084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443914004098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0925443914004098"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.12.015","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in the relationship of IL-6 signaling to cancer cachexia progression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2014.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}